Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q414030> ?p ?o }
Showing triples 1 to 70 of
70
with 100 triples per page.
- Q414030 subject Q15645290.
- Q414030 subject Q7297892.
- Q414030 subject Q7337151.
- Q414030 subject Q9052781.
- Q414030 abstract "Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and multiple sclerosis. Its chemical name is 2-chlorodeoxyadenosine (2CDA).As a purine analog, it is a synthetic anti-cancer agent that also suppresses the immune system. Chemically, it mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, which interferes with the cell's ability to process DNA. It is easily destroyed by normal cells except for blood cells, with the result that it produces relatively few side effects and results in very little non-target cell loss.".
- Q414030 atcPrefix "L01".
- Q414030 atcSuffix "BB04".
- Q414030 bioavailability "100.0".
- Q414030 casNumber "4291-63-8".
- Q414030 chEBI "567361".
- Q414030 drugbank "DB00242".
- Q414030 fdaUniiCode "47M74X9YT5".
- Q414030 iupacName "5-(6-Amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol".
- Q414030 pubchem "20279".
- Q414030 thumbnail Cladribine.svg?width=300.
- Q414030 wikiPageWikiLink Q101026.
- Q414030 wikiPageWikiLink Q1055374.
- Q414030 wikiPageWikiLink Q1057079.
- Q414030 wikiPageWikiLink Q1368197.
- Q414030 wikiPageWikiLink Q1411740.
- Q414030 wikiPageWikiLink Q1435822.
- Q414030 wikiPageWikiLink Q14864787.
- Q414030 wikiPageWikiLink Q15645290.
- Q414030 wikiPageWikiLink Q159.
- Q414030 wikiPageWikiLink Q17152512.
- Q414030 wikiPageWikiLink Q1765564.
- Q414030 wikiPageWikiLink Q190012.
- Q414030 wikiPageWikiLink Q201299.
- Q414030 wikiPageWikiLink Q2035485.
- Q414030 wikiPageWikiLink Q214747.
- Q414030 wikiPageWikiLink Q2779401.
- Q414030 wikiPageWikiLink Q28734.
- Q414030 wikiPageWikiLink Q30612.
- Q414030 wikiPageWikiLink Q3178930.
- Q414030 wikiPageWikiLink Q332498.
- Q414030 wikiPageWikiLink Q37187.
- Q414030 wikiPageWikiLink Q3824358.
- Q414030 wikiPageWikiLink Q421851.
- Q414030 wikiPageWikiLink Q466892.
- Q414030 wikiPageWikiLink Q492646.
- Q414030 wikiPageWikiLink Q5090632.
- Q414030 wikiPageWikiLink Q5445.
- Q414030 wikiPageWikiLink Q573538.
- Q414030 wikiPageWikiLink Q640448.
- Q414030 wikiPageWikiLink Q6593447.
- Q414030 wikiPageWikiLink Q7297892.
- Q414030 wikiPageWikiLink Q7337151.
- Q414030 wikiPageWikiLink Q7873.
- Q414030 wikiPageWikiLink Q793867.
- Q414030 wikiPageWikiLink Q8277.
- Q414030 wikiPageWikiLink Q864868.
- Q414030 wikiPageWikiLink Q9052781.
- Q414030 wikiPageWikiLink Q974135.
- Q414030 atcPrefix "L01".
- Q414030 atcSuffix "BB04".
- Q414030 bioavailability "100.0".
- Q414030 casNumber "4291".
- Q414030 chebi "567361".
- Q414030 drugbank "DB00242".
- Q414030 iupacName "5".
- Q414030 pubchem "20279".
- Q414030 unii "47".
- Q414030 type ChemicalSubstance.
- Q414030 type Drug.
- Q414030 type ChemicalObject.
- Q414030 type Thing.
- Q414030 type Q8386.
- Q414030 comment "Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and multiple sclerosis. Its chemical name is 2-chlorodeoxyadenosine (2CDA).As a purine analog, it is a synthetic anti-cancer agent that also suppresses the immune system. Chemically, it mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, which interferes with the cell's ability to process DNA.".
- Q414030 label "Cladribine".
- Q414030 depiction Cladribine.svg.